Clinical Outcomes of Drug-Coated Balloons in Coronary Artery Disease Unsuitable for Drug-Eluting Stent Implantation.
Two-year clinical outcome after abciximab-coated stent implantation in patients with coronary artery disease.
Randomized comparative study of diamond-like carbon coated stainless steel stent versus uncoated stent implantation in patients with coronary artery disease.
Drug-Coated Balloons in the Management of Coronary Artery Disease.
Korjian S, McCarthy KJ, Larnard EA, Cutlip DE, McEntegart MB, Kirtane AJ, Yeh RW.
Circ Cardiovasc Interv. 2024 May;17(5):e013302. doi: 10.1161/CIRCINTERVENTIONS.123.013302. Epub 2024 May 21.
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
Giacoppo D, Alvarez-Covarrubias HA, Koch T, Cassese S, Xhepa E, Kessler T, Wiebe J, Joner M, Hochholzer W, Laugwitz KL, Schunkert H, Kastrati A, Kufner S.
Eur Heart J. 2023 Apr 17;44(15):1343-1357. doi: 10.1093/eurheartj/ehad026.
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes.
Gitto M, Leone PP, Gioia F, Chiarito M, Latini A, Tartaglia F, Kilic ID, Rossi ML, Regazzoli D, Gasparini G, Cozzi O, Sticchi A, Condorelli G, Reimers B, Stefanini G, Mangieri A, Colombo A.
Am J Cardiol. 2025 Mar 15;239:28-35. doi: 10.1016/j.amjcard.2024.12.008. Epub 2024 Dec 10.
Drug-coated balloons for coronary artery disease: current concepts and controversies.
Buccheri D, Lombardo RM, Cortese B.
Future Cardiol. 2019 Nov;15(6):437-454. doi: 10.2217/fca-2019-0009. Epub 2019 Nov 5.
Vascular healing in high-bleeding-risk patients at 3-month after everolimus-eluting stent versus biolimus A9-coated stent implantation: insights from analysis of optical coherence tomography and coronary angioscopy.
Koiwaya H, Nishihira K, Kadooka K, Kuriyama N, Shibata Y.
Cardiovasc Interv Ther. 2023 Jan;38(1):64-74. doi: 10.1007/s12928-022-00877-9. Epub 2022 Aug 2.
Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.
Greco A, Sciahbasi A, Abizaid A, Mehran R, Rigattieri S, de la Torre Hernandez JM, Alfonso F, Cortese B.
Catheter Cardiovasc Interv. 2022 Oct;100(4):544-552. doi: 10.1002/ccd.30358. Epub 2022 Sep 2.
Coronary stent failure: role of a blended approach with drug-coated balloons for complex lesions.
Cortese B, Sanchez-Jimenez E, Lazar L.
Minerva Cardiol Angiol. 2024 Jun;72(3):266-280. doi: 10.23736/S2724-5683.22.06172-5. Epub 2023 Mar 20.
Angioscopic assessments and clinical outcomes one year after polymer-free biolimus A9-coated coronary stent implantation.
Tsujimura T, Ishihara T, Okuno S, Iida O, Kurata N, Asai M, Masuda M, Okamoto S, Nanto K, Kanda T, Matsuda Y, Hata Y, Mano T.
J Cardiol. 2021 May;77(5):457-464. doi: 10.1016/j.jjcc.2020.10.002. Epub 2020 Oct 26.
Clinical Outcomes of Self-Made Polyurethane-Covered Stent Implantation for the Treatment of Coronary Artery Perforations.
Song X, Qin Q, Chang S, Xu R, Fu M, Lu H, Ge L, Qian J, Ma J, Ge J.
J Interv Cardiol. 2021 May 17;2021:6661763. doi: 10.1155/2021/6661763. eCollection 2021.
Coronary artery stenting.
Ashby DT, Dangas G, Mehran R, Leon MB.
Catheter Cardiovasc Interv. 2002 May;56(1):83-102. doi: 10.1002/ccd.10209.
